Skip to main content
. 2023 Jan 17;28(3):931. doi: 10.3390/molecules28030931
4CzBnBN (2,3,4,6)-3-Benzyl-2,4,5,6-tetra(9H-carbazol-9-yl)benzonitrile
5-HT2A receptor 5-Hydroxy-tryptamine 2A receptor
AD Alzheimer’s disease
ALS Amyotrophic lateral sclerosis
Am Molar activity
AMPA receptor α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
BEMP 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine
CB2 receptor Cannabinoid receptor type 2
CNS Central nervous system
COX-1, -2 Cyclooxygenase-1, -2
CSF1 colony stimulating factor 1
CuTC Copper(I) thiophene-2-carboxylate
DBAD Di-tert-butyl azodicarboxylate
DBN 1,5-Diazabicyclo [4.3.0]non-5-ene
DBU 1,8-diazabicyclo [5.4.0]undec-7-ene
dc Decay-corrected
DCC N,N′-Dicyclohexylcarbodiimide
de Diastereomeric excess
DMA Dimethylacetamide
DMF Dimethylformamide
DMSO Dimethyl sulfoxide
DPSO Diphenyl sulfoxide
d.r. Diastereomeric ratio
dtbbpy 4,4’-Di-tert-butyl-2,2’-bipyridine
FIH First-in-human
FMDS Fluoride-mediated desilylation
HOSA Hydroxylamine-O-sulfonic acid
HPLC High-performance liquid chromatography
IPr 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene)
K222 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo [8.8.8]hexacosane
MAO-B Monoamine oxidase B
mGluR5 Metabotropic glutamate receptor 5
mHTT Mutant huntingtin protein
NMDA N-methyl-D-aspartate
NMP N-Methyl-2-pyrrolidone
PD Parkinson’s disease
PDE7 Phosphodiesterase 7
PET Positron emission tomography
ppy 2-Phenylpyridine
prec precursor
quant. quantitative
RCC Radiochemical conversion
RCP Radiochemical purity
RCY Radiochemical yield
Ref. Reference
rt Room temperature
t1/2 Half-life
TBAT Tetrabutylammonium difluorotriphenylsilicate
TBAI Tetra-n-butylammonium iodide
TE Trapping efficiency
THF Tetrahydrofuran
TMEDA Tetramethylethylenediamine
TMS Trimetylsilyl
TrkB/C Tropomyosin receptor kinase B/C
TSPO Translocator protein